Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron vs granisetron for prevention of chemotherapy-induced nausea and vomiting
jRCT2080220284Phase 3
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by Taiho Pharmaceutical Co., Ltd.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on jRCT2080220284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220284.